Wheatland Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$212K Buy
+6,847
New +$233K 0.88% 40
2020
Q1
Sell
-12,047
Closed -$448K 74
2019
Q4
$448K Sell
12,047
-12,777
-51% -$455K 0.57% 63
2019
Q3
$846K Sell
24,824
-20,338
-45% -$740K 0.77% 46
2019
Q2
$1.86M Sell
45,162
-105
-0.2% -$4.17K 1.4% 23
2019
Q1
$1.82M Sell
45,267
-159
-0.4% -$6.37K 1.39% 25
2018
Q4
$1.88M Hold
45,426
1.64% 21
2018
Q3
$1.9M Buy
45,426
+1,686
+4% +$64.9K 1.43% 22
2018
Q2
$1.51M Buy
43,740
+474
+1% +$16.2K 1.22% 28
2018
Q1
$1.46M Hold
43,266
1.2% 27
2017
Q4
$1.49M Hold
43,266
1.2% 27
2017
Q3
$1.47M Sell
43,266
-527
-1% -$16.9K 1.25% 25
2017
Q2
$1.4M Sell
43,793
-1,159
-3% -$36.5K 1.26% 27
2017
Q1
$1.46M Sell
44,952
-757
-2% -$23.9K 1.3% 25
2016
Q4
$1.41M Buy
45,709
+38
+0.1% +$1.16K 1.25% 28
2016
Q3
$1.47M Hold
45,671
1.38% 27
2016
Q2
$1.53M Sell
45,671
-527
-1% -$16.8K 1.47% 25
2016
Q1
$1.3M Hold
46,198
1.33% 26
2015
Q4
$1.42M Sell
46,198
-105
-0.2% -$3.3K 1.45% 25
2015
Q3
$1.38M Sell
46,303
-283
-0.6% -$9.07K 1.5% 26
2015
Q2
$1.48M Hold
46,586
1.42% 27
2015
Q1
$1.54M Hold
46,586
1.53% 27
2014
Q4
$1.38M Hold
46,586
1.34% 27
2014
Q3
$1.31M Hold
46,586
1.31% 29
2014
Q2
$229K Hold
46,586
0.21% 81
2014
Q1
$1.42M Hold
46,586
1.45% 27
2013
Q4
$1.35M Buy
+46,586
New +$1.36M 1.42% 28

Other funds holding PFE

Wheatland Advisors's PFE Position: Q2 2020 in Review

Wheatland Advisors opened a new position in Pfizer (PFE) in Q2 2020: 6,847 shares worth $212K. The stake represents 0.88% of the portfolio and ranks #40 among its holdings. This is a return to the name: Wheatland Advisors previously reported a position in PFE as recently as Q4 2019.

Wheatland Advisors first reported a position in PFE in Q4 2013 and has held it in 26 quarters since. The position peaked at $1.9M in Q3 2018. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Wheatland Advisors held 6,847 shares of Pfizer worth $212K as of Q2 2020.
  • Pfizer was a new Wheatland Advisors position in Q2 2020.
  • Pfizer made up 0.88% of Wheatland Advisors's portfolio in Q2 2020, its #40 holding.
  • Wheatland Advisors first reported a position in Pfizer in Q4 2013 and has held it in 26 quarters since.
  • Wheatland Advisors's Pfizer position peaked at $1.9M in Q3 2018.
  • 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Wheatland Advisors's 13F filing for Q2 2020, filed 28 Jul 2020.